335 related articles for article (PubMed ID: 31908656)
1. Hidradenitis suppurativa: infection, autoimmunity, or both?
Constantinou CA; Fragoulis GE; Nikiphorou E
Ther Adv Musculoskelet Dis; 2019; 11():1759720X19895488. PubMed ID: 31908656
[TBL] [Abstract][Full Text] [Related]
2. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
[TBL] [Abstract][Full Text] [Related]
3. Cytokine Pathways and Investigational Target Therapies in Hidradenitis Suppurativa.
Del Duca E; Morelli P; Bennardo L; Di Raimondo C; Nisticò SP
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33182701
[TBL] [Abstract][Full Text] [Related]
4. Cytokine-Mediated Molecular Pathophysiology of Hidradenitis Suppurativa: A Narrative Review.
Melchor J; Prajapati S; Pichardo RO; Feldman SR
Skin Appendage Disord; 2024 Jun; 10(3):172-179. PubMed ID: 38835710
[TBL] [Abstract][Full Text] [Related]
5. Primary alterations during the development of hidradenitis suppurativa.
Dajnoki Z; Somogyi O; Medgyesi B; Jenei A; Szabó L; Gáspár K; Hendrik Z; Gergely P; Imre D; Póliska S; Törőcsik D; Zouboulis CC; Prens EP; Kapitány A; Szegedi A
J Eur Acad Dermatol Venereol; 2022 Mar; 36(3):462-471. PubMed ID: 34724272
[TBL] [Abstract][Full Text] [Related]
6. Paradoxical Hidradenitis Suppurativa during Biologic Therapy, an Emerging Challenge: A Systematic Review.
Ruggiero A; Martora F; Picone V; Marano L; Fabbrocini G; Marasca C
Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203664
[TBL] [Abstract][Full Text] [Related]
7. The Pathogenesis and Treatment of Hidradenitis Suppurativa.
Agnese ER; Tariche N; Sharma A; Gulati R
Cureus; 2023 Nov; 15(11):e49390. PubMed ID: 38146560
[TBL] [Abstract][Full Text] [Related]
8. An Integrated Approach to Unravel Hidradenitis Suppurativa Etiopathogenesis.
Tricarico PM; Boniotto M; Genovese G; Zouboulis CC; Marzano AV; Crovella S
Front Immunol; 2019; 10():892. PubMed ID: 31105704
[TBL] [Abstract][Full Text] [Related]
9. New perspectives on the treatment of hidradenitis suppurativa.
Amat-Samaranch V; Agut-Busquet E; Vilarrasa E; Puig L
Ther Adv Chronic Dis; 2021; 12():20406223211055920. PubMed ID: 34840709
[TBL] [Abstract][Full Text] [Related]
10. Activity and components of the granulocyte colony-stimulating factor pathway in hidradenitis suppurativa.
Wolk K; Brembach TC; Šimaitė D; Bartnik E; Cucinotta S; Pokrywka A; Irmer ML; Triebus J; Witte-Händel E; Salinas G; Leeuw T; Volk HD; Ghoreschi K; Sabat R
Br J Dermatol; 2021 Jul; 185(1):164-176. PubMed ID: 33400270
[TBL] [Abstract][Full Text] [Related]
11. Serum high-sensitivity C-reactive protein, tumor necrosis factor-α, interleukin (IL)-1β, IL-17A and IL-23 levels in patients with hidradenitis suppurativa.
Saraç Öztürk G; Ergun T; Peker Eyüboğlu İ; Akkiprik M
Cytokine; 2021 Aug; 144():155585. PubMed ID: 34034145
[TBL] [Abstract][Full Text] [Related]
12. Boils at Frictional Locations in a Patient with Hidradenitis Suppurativa.
Boer J; Mihajlovic D
Acta Dermatovenerol Croat; 2016 Dec; 24(4):303-304. PubMed ID: 28128084
[TBL] [Abstract][Full Text] [Related]
13. Long-standing refractory hidradenitis suppurativa responded to a brodalumab monotherapy in a patient with psoriasis: A possible involvement of Th17 across the spectrum of both diseases.
Yoshida Y; Oyama N; Iino S; Shimizu C; Hasegawa M
J Dermatol; 2021 Jun; 48(6):916-920. PubMed ID: 33609416
[TBL] [Abstract][Full Text] [Related]
14. Hidradenitis suppurativa: from pathogenesis to diagnosis and treatment.
Napolitano M; Megna M; Timoshchuk EA; Patruno C; Balato N; Fabbrocini G; Monfrecola G
Clin Cosmet Investig Dermatol; 2017; 10():105-115. PubMed ID: 28458570
[TBL] [Abstract][Full Text] [Related]
15. The critical role of macrophages in the pathogenesis of hidradenitis suppurativa.
Shah A; Alhusayen R; Amini-Nik S
Inflamm Res; 2017 Nov; 66(11):931-945. PubMed ID: 28656364
[TBL] [Abstract][Full Text] [Related]
16. Keratinocytes and immune cells in the epidermis are key drivers of inflammation in hidradenitis suppurativa providing a rationale for novel topical therapies.
Schell SL; Cong Z; Sennett ML; Gettle SL; Longenecker AL; Goldberg SR; Kirby JS; Helm MF; Nelson AM
Br J Dermatol; 2023 Feb; 188(3):407-419. PubMed ID: 36680309
[TBL] [Abstract][Full Text] [Related]
17. Challenges in the Management of Perianal Hidradenitis Suppurativa in an African American Male: A Case Report.
Russell N; Kpughur-Tule N; Ravichandar E; Dorta Torres G; Tiesenga F
Cureus; 2023 Sep; 15(9):e45788. PubMed ID: 37872932
[TBL] [Abstract][Full Text] [Related]
18. The Association Between Hidradenitis Suppurativa and Diet: An Update.
Belamarić M; Miše J; Bukvić Mokos Z
Acta Dermatovenerol Croat; 2023 Dec; 31(4):213-219. PubMed ID: 38651848
[TBL] [Abstract][Full Text] [Related]
19. Phytotherapeuthics Affecting the IL-1/IL-17/G-CSF Axis: A Complementary Treatment Option for Hidradenitis Suppurativa?
Witte K; Sabat R; Witte-Händel E; Ghoreschi K; Wolk K
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012322
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of hidradenitis suppurativa symptoms in axial spondyloarthritis patients: A possible new extra-articular manifestation.
Rondags A; Arends S; Wink FR; Horváth B; Spoorenberg A
Semin Arthritis Rheum; 2019 Feb; 48(4):611-617. PubMed ID: 29751976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]